EFFECTS OF SELECTIVE DOPAMINE-D1 AND DOPAMINE-D2 RECEPTOR AGONISTS ON THE RATE OF GABA SYNTHESIS IN MOUSE-BRAIN

被引:16
作者
STEULET, AF
BERNASCONI, R
LEONHARDT, T
MARTIN, P
GRUNENWALD, C
BISCHOFF, S
HEINRICH, M
BANDELIER, V
MAITRE, L
机构
[1] Research Department, Pharmaceuticals Division, Ciba-Geigy Ltd.
关键词
Brain (mouse); Dopamine D[!sub]1[!/sub] receptors; Dopamine D[!sub]2[!/sub] receptors; GABA synthesis (rate of); Gabaculine;
D O I
10.1016/0014-2999(90)94092-C
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of dopamine D1 and D2 receptor agonists and antagonists on the rate of GABA synthesis in four regions of mouse brain (corpus striatum, cerebellum, cortex and hippocampus) were examined after irreversible inhibition of 4-anunobutyrate: 2-oxoglutarate aminotransferase (EC 2.6.1.19; GABA-T) by gabaculine. The dopamine D2 receptor agonists PPHT, LY 171555 and RU 24213 exerted a dose-related inhibitory effect on GABA synthesis in these four regions. The decreases in the rate of GABA formation were prevented by the dopamine D2 receptor antagonist S(-)-sulpiride. The dopamine D1 receptor agonists SKF 77434 and SKF 38393 augmented gabacutme-induced GABA accumulation in the corpus striatum only, and this effect was blocked by the dopamine D1 receptor antagonist SCH 23390. However, SKF 81297 and SKF 82958, two other dopamine D1 receptor agonists, did not affect or only marginally altered the rate of GABA synthesis. Stimulation of D2 receptors thus induces a decrease in the rate of GABA formation in the four brain areas examined, whereas stimulation of D1 receptors either increases GABA synthesis in the corpus striatum or does not alter it. This effect appears to be independent of the degree of receptor occupancy. © 1990.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 50 条
[1]   DOPAMINE RECEPTOR SUBTYPES - BEYOND THE D1/D2 CLASSIFICATION [J].
ANDERSEN, PH ;
GINGRICH, JA ;
BATES, MD ;
DEARRY, A ;
FALARDEAU, P ;
SENOGLES, SE ;
CARON, MG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (06) :231-236
[2]   INHIBITION BY APOMORPHINE OF THE POTASSIUM-EVOKED RELEASE OF (H-3)-GAMMA-AMINOBUTYRIC ACID FROM THE RAT SUBSTANTIA NIGRA INVITRO [J].
ARBILLA, S ;
KAMAL, LA ;
LANGER, SZ .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 74 (02) :389-397
[3]   SYNERGISTIC INTERACTION BETWEEN DOPAMINE D-1 AND D-2 RECEPTOR AGONISTS - CIRCLING BEHAVIOR OF RATS WITH HEMITRANSECTION [J].
ARNT, J ;
PERREGAARD, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 143 (01) :45-53
[4]  
ARNT K, 1988, PHARMACOL TOXICOL, V62, P1
[5]   THE USE OF INHIBITORS OF GABA-TRANSAMINASE FOR THE DETERMINATION OF GABA TURNOVER IN MOUSE-BRAIN REGIONS - AN EVALUATION OF AMINOOXYACETIC ACID AND GABACULINE [J].
BERNASCONI, R ;
MAITRE, L ;
MARTIN, P ;
RASCHDORF, F .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (01) :57-66
[6]   THE SPECIFIC PROTECTIVE EFFECT OF DIAZEPAM AND VALPROATE AGAINST ISONIAZID-INDUCED SEIZURES IS NOT CORRELATED WITH INCREASED GABA-LEVELS [J].
BERNASCONI, R ;
KLEIN, M ;
MARTIN, P ;
PORTET, C ;
MAITRE, L ;
JONES, RSG ;
BALTZER, V ;
SCHMUTZ, M .
JOURNAL OF NEURAL TRANSMISSION, 1985, 63 (02) :169-189
[7]  
BERNASCONI R, 1986, ARCH PHARM, V334, pR47
[8]  
BERNASCONI R, 1981, BASIC MECHANISMS ACT, P183
[9]  
BERNASSCONI R, 1989, Encephale, V15, P377
[10]   DOPAMINE MAY INFLUENCE STRIATAL GABA RELEASE VIA 3 SEPARATE MECHANISMS [J].
BERNATH, S ;
ZIGMOND, MJ .
BRAIN RESEARCH, 1989, 476 (02) :373-376